Tag - Miles Minter

William Blair launched coverage of Silence Therapeutics (NASDAQ:SLN) with an “outperform” rating and fair value estimate of $31. The stock closed at $15.50 on Oct. 26. Silence Therapeutics is developing a GalNAc...